Filing Flows

Filing Flows › Materials › United States Antimony (UAMY)

United States Antimony (UAMY) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 11, 2026 · United States Antimony (UAMY) Q2 2026 earnings results →

Q2 2026 Revenue down 25% year over year to $7.9M · 1¢ of every $1 of revenue kept as net profit · operating margin -88.1%

United States Antimony made $7.9M in Q2 2026 (-25% Y/Y): Antimony $5.9M, Zeolite $1.9M, Precious metals $197K. Operating margin -88.1%, net earnings $110K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 11, 2026.

Revenue$7.9M
Year over year-25%
Operating margin-88.1%
Net earnings$110K
Operating cash flow−$8.7M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $7.9M in Q2 2026, down 25% year over year and up 17% from the previous quarter. Antimony was the largest line at 74% of revenue. Antimony lost $3.8M year over year (down 39%), 145% of the total change.

Gross margin was 7.4%, down 19.6 points from Q2 2025. Operating costs exceeded revenue by $7.0M, an operating margin of -88.1%. Operating expenses grew 168% against a revenue fall of 25%. The fastest-growing cost line was Other operating costs (+202%). Net earnings were $110K, down 39% year over year. The effective tax rate was 0.0%. Non-operating items added $7.1M, 6430% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was −$8.7M. Non-cash charges added back $515K of depreciation and amortization and $2.9M of share-based compensation. Working capital and other items used $12.2M. Capital expenditures of $10.2M exceeded it, leaving free cash flow of −$18.9M.

Quarterly history

United States Antimony revenue by quarterUnited States Antimony revenue by quarter$6.9MQ4 2024$7.0MQ1 2025$10.5MQ2 2025$8.7MQ3 2025$13.0MQ4 2025$6.8MQ1 2026$7.9MQ2 2026
United States Antimony net earnings by quarterUnited States Antimony net earnings by quarter−$883KQ4 2024$547KQ1 2025$182KQ2 2025−$4.8MQ3 2025−$287KQ4 2025−$11.3MQ1 2026$110KQ2 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 202610-QAug 11, 2026$7.9M-25%-88.1%$110K−$8.7M
Q1 202610-QMay 14, 2026$6.8M-3%-110.8%−$11.3M−$12.1M
Q4 202510-KMar 19, 2026$13.0M+131%-30.1%−$287K−$3.5M
Q3 202510-QNov 12, 2025$8.7M+238%-56.5%−$4.8M−$3.9M
Q2 202510-QAug 12, 2025$10.5M+187%0.2%$182K−$628K
Q1 202510-QMay 8, 2025$7.0M+128%5.1%$547K−$1.7M
Q4 202410-KMar 20, 2025$6.9M+219%-18.4%−$883K$1.2M

Charts

United States Antimony: revenue growth, year over year and quarter over quarterUnited States Antimony: revenue growth, year over year and quarter over quarterY/YQ/Q+219%Q4 2024+128%+2%Q1 2025+187%+50%Q2 2025+238%-17%Q3 2025+131%+50%Q4 2025-3%-48%Q1 2026-25%+17%Q2 2026
Latest (Q2 2026): Y/Y -25%, Q/Q +17%.
United States Antimony: where the cash came from (+) and went (−), TTM to Q2 2026United States Antimony: where the cash came from (+) and went (−), TTM to Q2 2026Net borrowing (+) / repaid (−)$148MCapital spending−$43.2MOther investing−$37.9MCash drawn (+) / kept (−)−$36.4MOperating cash flow−$28.1MOther financing−$2.8MShares issued$322KAsset & business sales$15K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
United States Antimony: profit against cash, quarter by quarterUnited States Antimony: profit against cash, quarter by quarterNet incomeOperating cash flow−$728K$411KQ3 2024−$883K$1.2MQ4 2024$547K−$1.7MQ1 2025$182K−$628KQ2 2025−$4.8M−$3.9MQ3 2025−$287K−$3.5MQ4 2025−$11.3M−$12.1MQ1 2026$110K−$8.7MQ2 2026
Latest (Q2 2026): Net income $110K, Operating cash flow −$8.7M.
United States Antimony: diluted shares by fiscal yearUnited States Antimony: diluted shares by fiscal year73MFY2020106MFY2022108MFY2023109MFY2024124MFY2025
+70.5% since FY2020: more shares outstanding (issuance, stock pay).
United States Antimony: long-term debt falling due (FY2024)United States Antimony: long-term debt falling due (FY2024)$132K2025$137K2026$58K2027
Cash $18.2M, short-term investments —, long-term debt $195K at 2024-12-31.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About United States Antimony

United States Antimony Corporation’s (“US Antimony,” “USAC,” the “Company,” “we,” “us,” and “our,”) principal business is in the mining, procuring, processing and sale of antimony and precious metals, primarily gold and silver, in Montana and Mexico, and the mining, processing, and sale of zeolite in Idaho. Beginning in late 2024 and continuing in 2025, the Company acquired mining claims in Alaska, Montana, and Canada prospective for antimony, tungsten, cobalt and other critical minerals. In addition, the Company entered into an agreement to acquire exploration rights for mining properties located in the southeastern United States. The Company also procured antimony ore from new international suppliers and is nearing construction completion of an expansion of its antimony processing facility located in Montana that is expected to more than triple its current capacity.

In its own words, from its 10-K, filed Mar 19, 2026.

Source: United States Antimony 10-Q on SEC EDGAR · CIK 101538 · Primary Smelting & Refining of Nonferrous Metals

13F: who owns UAMY and who is buying

Largest holders of UAMY (13F)Largest holders of UAMY (13F)BlackRock$82.4MState Street$82.3MPrice T Rowe Associates$72.8MVan ECK Associates$62.1MVanguard Capital Management LLC$40.1MVanguard Group$37.3MFrontier Capital Management Co LLC$31.2MGeode Capital Management, LLC$23.8MDavidson Kempner Capital Manageme…$18.4MTruist Financial$15.6M
Funds' net buying of UAMY by quarter (13F)Funds' net buying of UAMY by quarter (13F)$769K2024-09−$243K2024-12$9.9M2025-03$28.3M2025-06$82.5M2025-09$68.5M2025-12$107M2026-03$130M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on UAMY

History

Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results

中文版:United States Antimony(UAMY)财报

Español · Français